Anabelle Colaco
16 Nov 2026, 11:57 GMT+10
NEW YORK CITY, New York: Employers and other health plan sponsors could break even on GLP-1 weight-loss and diabetes drugs if prices fell below $350 per month, CVS Health said, as savings from fewer hospitalizations and emergency room visits would then offset the cost of the medicines.
At current prices, the drugs add to spending because they are too high to be impacted by lower medical costs, CVS said, citing an analysis of its Aetna insurance claims data across patients with obesity, diabetes or other conditions.
Over three years, plan sponsors saved $9,400 per person on medical bills, but spent $13,300 more on prescriptions, adding costs of $3,900 per person, according to the analysis.
The analysis looked at patients who were newly taking highly popular GLP-1 medicines — which mimic the GLP-1 hormone and reduce appetite — from Eli Lilly and Novo Nordisk, and compared them to similar patients who were not taking the drugs. The drugs included Mounjaro and Ozempic for diabetes and Zepbound and Wegovy for obesity. The analysis covered periods of up to three years, with patients starting the medicines between 2023 and 2025. It did not break out figures for obesity patients alone.
Coverage of GLP-1 drugs for obesity is falling as corporations and other health plan sponsors try to bring down premiums expected to be up by over 9% in 2027. About 14% of companies have already dropped or plan to drop the drugs in 2027.
Zepbound and Wegovy can cost about $299 and $349 for cash-pay customers. Employers and other health plan sponsors pay between $617 and $766 monthly for the drugs, according to a 2025 study by the Employee Benefit Research Institute. CVS declined to comment on the average prices paid.
Dr Amy Compton-Phillips, chief medical officer at CVS Health, said that the drugmakers' direct-to-consumer prices suggest they can still profit by charging less than $350 a month, while also helping to lower overall healthcare costs.
"I hope that we can reach that price sooner rather than later," she said in an interview.
The US government agreed on a deal with Lilly and Novo last year to pay $245 per month for injectable GLP-1 weight-loss drugs in an 18-month pilot testing their cost-effectiveness for Medicare beneficiaries aged 65 and older or with disabilities.
CVS said GLP-1 use was associated with 10-12% lower emergency room visits in the first and second year of use. An analysis of records for 4,000 people still taking the drug after three years showed a decrease in hospitalizations of 34-42%, according to the report.
The company, which also operates pharmacy benefit manager Caremark, said the price at which GLP-1s start saving money overall depends on how healthy or sick a patient is.
"An older person with diabetes is going to have a higher risk for hospitalization than a younger person who is obese without diabetes," said Compton-Phillips. "The higher-risk the person is, the quicker you get to a return on investment."
Get a daily dose of Milwaukee Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Milwaukee Sun.
More InformationBUDAPEST, Hungary: Hungarian authorities have recovered nearly US$20 million in cash hidden in forests, farm buildings, warehouses...
ASUNCION, Paraguay: Paraguayan prosecutors have expanded their corruption investigation into the collapse of digital bank ueno, adding...
TAIPEI, Taiwan: China has carried out a large, unannounced military exercise across the western Pacific and around Taiwan, deploying...
TEHRAN, Iran, November 15 (ANI): Iran's Foreign Ministry spokesperson Esmaeil Baqaei on Saturday (local time) slammed the US narrative...
BUDAPEST, Hungary: The world-famous Rubik's Cube is returning to its birthplace in Hungary, more than 50 years after its invention....
BEIJING, China: Chinese President Xi Jinping has renewed his call for Taiwan's reunification with China, saying it was an unavoidable...
WASHINGTON, D.C.: US safety regulators have urged owners of more than 720,000 BMW vehicles to park outside until repairs can be completed,...
WASHINGTON, D.C.: Sales of previously owned US homes fell in October to their lowest level in more than 16 years, as rising mortgage...
(Photo credit: Michael McLoone) Nickeil Alexander-Walker scored 20 points and Onyeka Okongwu added 16 with 11 rebounds to lead the...
(Photo credit: Kayla Wolf) Owen Foxwell scored 27 of his game-high 33 points in the second half to help Wisconsin overcome a lackluster...
(Photo credit: Robert Deutsch) New England Patriots quarterback Drake Maye and Detroit Lions defensive end Aidan Hutchinson were...
(Photo credit: Charles LeClaire) The World Series champion Milwaukee Brewers obtained right-hander Ryan Walker from the San Francisco...
